Advertisement

Surgery pp 323-351 | Cite as

Perioperative Management

  • Philip S. Barie

Abstract

Perioperative care, put simply, is the medical care provided to prepare a patient for surgery and to hasten recovery thereafter. Perioperative patient care is as integral to the outcome of the patient as the operation itself. In many cases, quality care may be more important to the achievement of a good outcome than the operation (e.g., when a major complication occurs after minor surgery or when a patient with complex medical problems must be managed for a straightforward operation). The simplicity of these statements belies the complexity of the issues because numerous fundamental questions must be addressed before considering the specifics involved. What is the duration of the perioperative period, and what marks its beginning and end? What constitutes a good outcome, and from the perspective of whom—the physician, the patient, or some external agency? What constitutes quality care, how can quality be measured, and are there characteristics of high-quality providers or units that are worthy of emulation? What standards of evidence should be applied for the evaluation of efficacy and effectiveness, and what are their flaws? Even the question of who should provide perioperative care is debated, especially for the hospitalized and seriously ill patient.

Keywords

Intensive Insulin Therapy Malignant Hyperthermia Noncardiac Surgery Intermittent Pneumatic Compression Acute Acalculous Cholecystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rao PM, Rhea JT, Novelline RA, et al. Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med 1998;338:141–146.PubMedCrossRefGoogle Scholar
  2. 2.
    Miller W, Riehl E, Napier M, et al. Use of physician assistants as surgery/trauma housestaff at an American College of Surgeons-verified level II trauma center. J Trauma 1998;44:372–376.PubMedCrossRefGoogle Scholar
  3. 3.
    Ghorra S, Reinert SE, Cioffi W, et al. Analysis of the effect of conversion from open to closed surgical invensive care unit. Ann Surg 1999;229:163–171.PubMedCrossRefGoogle Scholar
  4. 4.
    Trunkey DD. An unacceptable concept. Ann Surg 1999;229:172–173.PubMedCrossRefGoogle Scholar
  5. 5.
    Barie PS, Hydo LJ. Learning to not know: results of a program for ancillary cost reduction in surgical critical care. J Trauma 1996;41:714–720.PubMedCrossRefGoogle Scholar
  6. 6.
    Barie PS, Hydo LJ. Lessons learned: durability and progress of a program for ancillary cost reduction in surgical critical care. J Trauma 1997;43:590–596.PubMedCrossRefGoogle Scholar
  7. 7.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. An evaluation of outcome from intensive care in major medical centers. Ann Intern Med 1986;104:410–418.PubMedGoogle Scholar
  8. 8.
    Daley J, Forbes MG, Young GJ, et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. J Am Coll Surg 1997;185:341–351.PubMedGoogle Scholar
  9. 9.
    Hanson CW III, Deutschman CS, Anderson HL III, et al. Effects of an organized critical care service on outcomes and resource utilization: a cohort study. Crit Care Med 1999;27:270–274.PubMedCrossRefGoogle Scholar
  10. 10.
    Pronovost PJ, Jenckes MW, Durman T, et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999;281:1310–1317.PubMedCrossRefGoogle Scholar
  11. 11.
    Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221:43–49.PubMedCrossRefGoogle Scholar
  12. 12.
    Glasgow RE, Showstack JA, Katz PP, et al. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999;134:30–35.PubMedCrossRefGoogle Scholar
  13. 13.
    Kenny SE, Shankar KR, Rintala R, et al. Evidence-based surgery: interventions in a regional paediatric surgical unit. Arch Dis Child 1997;76:50–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Sugerman HJ, Wolfe L, Pasquale MD, et al. Multicenter, randomized, prospective trial of early tracheostomy. J Trauma 1997;43:741–747.PubMedCrossRefGoogle Scholar
  15. 15.
    Solomon MJ, McLeod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 1995;118:459–467.PubMedCrossRefGoogle Scholar
  16. 16.
    Romano PS, Roos LL, Luft HS, et al. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994;47:249–260.PubMedCrossRefGoogle Scholar
  17. 17.
    Egger M, Snith GD, Phillips AN. Meta-analysis: principles and procedures. Br Med J 1997;315:1533–1537.Google Scholar
  18. 18.
    Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609–613.PubMedCrossRefGoogle Scholar
  19. 19.
    Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996;275:308–314.PubMedCrossRefGoogle Scholar
  20. 20.
    Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998;17:841–856.PubMedCrossRefGoogle Scholar
  21. 21.
    Davey Smith G, Egger M. Meta-analysis. Unresolved issues and future developments. Br Med J 1998;316:221–225.Google Scholar
  22. 22.
    Flather MD, Farkouh ME, Pogue JM, Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Controlled Clin Trials 1997;18:568–579.PubMedCrossRefGoogle Scholar
  23. 23.
    Blumenthal D. Quality of health care. Part 1. Quality of care—what is it? N Engl J Med 1996;335:891–894.PubMedCrossRefGoogle Scholar
  24. 24.
    Brook RH, Cleary PD. Quality of health care. Part 2. Measuring quality of care. N Engl J Med 1996;335:966–970.PubMedCrossRefGoogle Scholar
  25. 25.
    Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study. II. N Engl J Med 1991;324:377–384.PubMedGoogle Scholar
  26. 26.
    Leape LL, Brennan TA, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study. N Engl J Med 1991;324:370–376.PubMedGoogle Scholar
  27. 27.
    Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997;349:309–313.PubMedCrossRefGoogle Scholar
  28. 28.
    Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events and potential adverse drug events: Implications for prevention. JAMA 1995;274:29–34.PubMedCrossRefGoogle Scholar
  29. 29.
    Leape LL. Error in medicine. JAMA 1994;272:1851–1857.PubMedCrossRefGoogle Scholar
  30. 30.
    Velanovich V. Using quality-of-life instruments to assess surgical outcomes. Surgery 1999;126:1–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Fitzpatrick R, Fletcher A, Gore S, et al. Quality-of-life measures in healthcare. Applications and issues in assessment. Br Med J 1992;305:1074–1077.CrossRefGoogle Scholar
  32. 32.
    Gill TM, Feinstein AR. A critical appraisal of quality of life measurements. JAMA 1994;272:619–626.PubMedCrossRefGoogle Scholar
  33. 33.
    Fletcher A, Gore S, Jones O, et al. Quality of life measures in healthcare. II. Design, analysis, and interpretation. Br Med J 1992;305:1145–1148.CrossRefGoogle Scholar
  34. 34.
    Goldman L. Cardiac risk for vascular surgery. J Am Coll Cardiol 1996;27:799–802.PubMedCrossRefGoogle Scholar
  35. 35.
    Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713–1720.PubMedCrossRefGoogle Scholar
  36. 36.
    Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789–1794.PubMedCrossRefGoogle Scholar
  37. 37.
    Charlson ME, MacKenzie CR, Gold JP, et al. Risk for postoperative congestive heart failure. Surg Gynecol Obstet 1991;172:95–104.PubMedGoogle Scholar
  38. 38.
    Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845–850.PubMedGoogle Scholar
  39. 39.
    Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996;27:910–948.PubMedCrossRefGoogle Scholar
  40. 40.
    Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913–920.PubMedCrossRefGoogle Scholar
  41. 41.
    Mangano DT, Hollenberg M, Fegert G, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery. I. Incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 1991;17:843–850.PubMedGoogle Scholar
  42. 42.
    Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk statification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144:581–595.PubMedGoogle Scholar
  43. 43.
    Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144:596–608.PubMedGoogle Scholar
  44. 44.
    Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998;114(suppl 5):531S–560S.PubMedCrossRefGoogle Scholar
  45. 45.
    Palmer AJ, Schramm W, Kirchhof B, Bergemann R. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials. Haemostasis 1997;27:65–74.PubMedGoogle Scholar
  46. 46.
    Wattsman TA, Davies RS. The utility of preoperative laboratory testing in general surgery patients for outpatient procedures. Am Surg 1997;63:81–90.PubMedGoogle Scholar
  47. 47.
    Salem M, Tainsh RE Jr, Bromberg J, et al. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 1994;219:416–425.PubMedCrossRefGoogle Scholar
  48. 48.
    Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. Br Med J 1998;316:961–964.Google Scholar
  49. 49.
    Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999;27:639–660.CrossRefGoogle Scholar
  50. 50.
    Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome (SIRS) to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg 1999;134:81–87.PubMedCrossRefGoogle Scholar
  51. 51.
    Barie PS, Jones WG. Multiple organ failure. In: Barie PS, Shires GT, eds. Surgical Intensive Care. Boston: Little Brown, 1993;147–207.Google Scholar
  52. 52.
    Eachempati SR, Reed RL II, Barie PS. Serum bicarbonate concentration correlates with arterial base deficit in critically ill patients. Surg Infect 2003;4:193–198.CrossRefGoogle Scholar
  53. 53.
    Gore DC, Jahoor F, Hibbert JM, De Maria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996;224:97–102.PubMedCrossRefGoogle Scholar
  54. 54.
    Shah MR, Hasselblad V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients. Meta-analysis of randomized clinical trials. JAMA 2005;294:1664–1670.PubMedCrossRefGoogle Scholar
  55. 55.
    Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 collaborative group. N Engl J Med 1995;333:1025–1032.PubMedCrossRefGoogle Scholar
  56. 56.
    Velmahos GC, Oemetriades O, Shoemaker WC, et al. Endpoints of resuscitation of critically injured patients: normal or supra-normal? A prospective randomized trial. Ann Surg 2000;232:409–418.PubMedCrossRefGoogle Scholar
  57. 57.
    Simon TL, Alverson DC, Au Buchon J, et al. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998;122:130–138.PubMedGoogle Scholar
  58. 58.
    Innes G. Guidelines for red blood cells and plasma transfusion for adults and children: an emergency physician’s overview of the 1997 Canadian blood transfusion guidelines. Part 1: red blood cell transfusion. Canadian Medical Association Expert Working Group. J Emerg Med 1998;16:129–131.PubMedCrossRefGoogle Scholar
  59. 59.
    Spiess BD, Let C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1998;116:460–467.PubMedCrossRefGoogle Scholar
  60. 60.
    Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409–417.PubMedCrossRefGoogle Scholar
  61. 61.
    Devlin JW, Welage LS, Olsen KM. Proton pump inhibitor formulary considerations in the acutely ill. Part 1: pharmacology, pharmacodynamics, and available formulations. Ann Pharmacother 2005;39:1667–1677.PubMedCrossRefGoogle Scholar
  62. 62.
    Devlin JW, Welage LS, Olsen KM. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: clinical efficacy, safety, and economics. Ann Pharmacother 2005;39:1844–1851.PubMedCrossRefGoogle Scholar
  63. 63.
    Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004;32:2008–2013.PubMedCrossRefGoogle Scholar
  64. 64.
    Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377–381.PubMedCrossRefGoogle Scholar
  65. 65.
    Barie PS, Eachempati SR. Acute acalculous cholecystitis. Curr Opin Gastorenterol 2003;5:302–309.Google Scholar
  66. 66.
    Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998;280:2013–2019.PubMedCrossRefGoogle Scholar
  67. 67.
    Zaloga GP. Early enteral nutritional support improves outcome: fact or fancy? Crit Care Med 1999;27:259–261.PubMedCrossRefGoogle Scholar
  68. 68.
    Cotterill AM, Mendel P, Holly JM, et al. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2, and 3 after elective abdominal surgery. Clin Endocrinol 1996;44:91–101.CrossRefGoogle Scholar
  69. 69.
    Kaufman FR, Devgan S, Roe TF, Costin G. Perioperative management with prolonged intravenous insulin infusion versus subcutaneous insulin in children with type I diabetes mellitus. J Diabetes Complications 1996;10:6–11.PubMedCrossRefGoogle Scholar
  70. 70.
    Thorell A, Efendic S, Gutmak M, et al. Insulin resistance after abdominal surgery. Br J Surg 1994;81:59–63.PubMedCrossRefGoogle Scholar
  71. 71.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359–1367.PubMedCrossRefGoogle Scholar
  72. 72.
    Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359–366.PubMedCrossRefGoogle Scholar
  73. 73.
    Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004;164:2005–2011.PubMedCrossRefGoogle Scholar
  74. 74.
    Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449–461.PubMedCrossRefGoogle Scholar
  75. 75.
    Mackenzie CR, Charlson ME. Assessment of perioperative risk in the patient with diabetes mellitus. Surg Gynecol Obstet 1988;167:293–299.PubMedGoogle Scholar
  76. 76.
    Clement R, Ronson JA, Engelman RU, Breyer RH. Perioperative morbidity in diabetics requiring coronary artery bypass surgery. Ann Thorac Surg 1988;46:321–323.PubMedCrossRefGoogle Scholar
  77. 77.
    Pomposelli JJ, Baxter JK III, Bakineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77–81.PubMedCrossRefGoogle Scholar
  78. 78.
    Jwasaka H, Itoh K, Myakawa H, et al. Glucose intolerance during prolonged sevoflurane anaesthesia. Can J Anaesth 1996;43:1059–1061.Google Scholar
  79. 79.
    Uchida I, Asoh T, Shirasaka C, Tsuji H. Effect of epidural analgesia on postoperative insulin resistance as evaluated by insulin clamp technique. Br J Surg 1988;75:557–562.PubMedCrossRefGoogle Scholar
  80. 80.
    Svedjeholu R, Hakanson E, Vanhaneu I. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIP) in cardiac surgery. Ann Thorac Surg 1995;59(suppl 2):515–522.Google Scholar
  81. 81.
    Svedjeholu R, Ekroth R, Joachinersson PO, Tyden H. High-dose insulin improves the efficacy of dopamine early after cardiac surgery. A study of myocardial performance and oxygen consumption. Scand J Thorac Cardovasc Surg 1991;25:215–221.Google Scholar
  82. 82.
    Svensson S, Ekroth R, Nilsson F, et al. Insulin as a vasodilating agent in the first hour after cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1989;23:139–143.PubMedGoogle Scholar
  83. 83.
    Svensson S, Ekroth R, Milocco I, et al. Glucose and lactate balances in heart and leg after coronary surgery: influence of insulin infusion. Scand J Thorac Cardiovasc Surg 1989;23:145–150.PubMedGoogle Scholar
  84. 84.
    Brandi LS, Fredian M, Oleggini M, et al. Insulin resistance after surgery: normalization by insulin treatment. Clin Sci 1990;79:443–450.PubMedGoogle Scholar
  85. 85.
    O’Grady NP, Barie PS, Bartlett JG, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis 1998;26:1042–1059.PubMedCrossRefGoogle Scholar
  86. 86.
    Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor alpha (TNF-a), interleukin-1, amid interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF-a and IL-6 levels and febrile transfusion reaction. Transfusion 1993;33:195–199.PubMedCrossRefGoogle Scholar
  87. 87.
    Montgomery KD, Potter HG, Helfet DL. Magnetic resonance venography to evaluate the deep venous system of the pelvis in patients who have an acetabular fracture. J Bone Joint Surg [Am] 1995;77:1639–1649.PubMedGoogle Scholar
  88. 88.
    Ferretti GR, Bosson JL, Buffaz PD, et al. Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs. Radiology 1997;205:453–458.PubMedGoogle Scholar
  89. 89.
    Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:438–473.PubMedCrossRefGoogle Scholar
  90. 90.
    Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 1997;46(RR-1):1–79.Google Scholar
  91. 91.
    Talmor M, Li P, Barie PS. Acute paranasal sinusitis in critically ill patients: guidelines for prevention, diagnosis and treatment. Clin Infect Dis 1997;25:1441–1446.PubMedCrossRefGoogle Scholar
  92. 92.
    Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994;106:221–235.PubMedCrossRefGoogle Scholar
  93. 93.
    Croce MA, Fabian TC, Waddle-Smith L, et al. Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227:743–751.PubMedCrossRefGoogle Scholar
  94. 94.
    Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261–267.PubMedCrossRefGoogle Scholar
  95. 95.
    Bartlett JG, Perl TM. The new Clostridium difficile—what does it mean? N Engl J Med 2005;353:2503–2505.PubMedCrossRefGoogle Scholar
  96. 96.
    McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–2441.PubMedCrossRefGoogle Scholar
  97. 97.
    Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.PubMedCrossRefGoogle Scholar
  98. 98.
    Kollef MH. Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease? Heart Lung 1994;23:363–367.PubMedGoogle Scholar
  99. 99.
    Darby JM, Linden P, Pasculle W, Saul M. Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med 1997;25:989–994.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Philip S. Barie
    • 1
    • 2
  1. 1.Departments of Surgery and Public HealthNewYork-Presbyterian Hospital/Weill Cornell Medical CollegeNew YorkUSA
  2. 2.Division of Critical Care and TraumaNewYork-Presbyterian Hospital/Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations